Fischer Medical Ventures Ltd Share Price Target 2026, 2030, 2035 | Updated May 2026
Fischer Medical Ventures Ltd share price today: ₹37.90 | Next market-day median forecast: ₹32.22 (2026-05-18) | 10–90% range: ₹32.22–₹32.22 | Forecast confidence: 63.8% | Chance of upside: 0.0% | Intrinsic value: ₹5.10 | 2027 target: ₹73.93 | 2036 target: ₹224.30
The next market-day median forecast for Fischer Medical Ventures Ltd (2026-05-18) is ₹32.22 which is 14.99% lower than today’s share price of ₹37.90 with a 10–90% range of ₹32.22–₹32.22. The estimate uses available price history, volatility, trend behaviour and intrinsic value gap.
Interactive Share Price Forecast
Choose tomorrow, day after, weekly, monthly or custom trading-day horizons and adjust assumptions to view possible price ranges.
Scenario controls
Uses trading-day intervals for short-term and long-term forecast views.
1 = next market day, 2 = day after, 21 ≈ one trading month.
Scenario adjusts assumptions for cautious, normal or optimistic market conditions.
Wider bands show more uncertainty; narrower bands show central outcomes.
Higher volatility widens the forecast range.
Higher influence gives more weight to intrinsic value in the forecast.
Target date--
Median forecast--
Expected return--
Selected range--
Chance of upside--
Confidence--
Horizon
Target date
Median forecast
Range
Return
Chance of upside
Forecast guide: Explore possible future price ranges using available price history, intrinsic value trend, volatility and valuation gap. Estimates update as fresh market and valuation data become available.
Fischer Medical Ventures Ltd – Investor Insights
Valuation StatusiCompares the stock's intrinsic value (calculated from fundamentals like earnings, book value, and growth) with the current market price (CMP). Undervalued = potential buying opportunity. Overvalued = the market may be pricing in too much optimism.
Overvalued
Intrinsic ₹5.10 vs CMP ₹37.90 (-86.5%)
Market RegimeiShows whether the stock is in an uptrend (bullish) or downtrend (bearish) based on its Exponential Moving Average (EMA). When price is above EMA → bullish momentum. Below EMA → bearish pressure. This affects how our model adjusts volatility and predictions.
▼ Bearish
Price/EMA: 0.317 · EMA(252): ₹119.68
VolatilityiMeasures how much the stock price swings. Low (<25%) = stable, predictable price movement. Moderate (25-40%) = normal for most stocks. High (>40%) = large daily swings, higher risk. The "recent trend" shows if volatility is currently increasing or decreasing compared to its historical average.
348% annualized
Risk: High · Recent trend: Falling (recent < historical)
Trend MemoryiThe Hurst Exponent measures whether price movements tend to continue (trending) or reverse (mean-reverting). Above 0.55 = momentum persists, recent trends likely to continue. Below 0.45 = price tends to snap back after big moves. Around 0.5 = random walk, past moves don't predict future direction.
Mean-reverting
Hurst exponent: 0.394
Projected CAGRiCompound Annual Growth Rate — the average yearly return if the stock reaches our projected price target. 5Y and 10Y show different time horizons. Higher CAGR = faster expected growth. Negative CAGR = the model projects the stock may decline from current levels.
+16.7%5Y+19.5%10Y
Historical drift: -119.2% annualized
Risk-Reward RatioiCompares your potential upside (to intrinsic value) against potential downside (to fundamental floor). Above 2x = favorable risk-reward, potential gain is at least double the potential loss. Below 1x = unfavorable, you risk losing more than you could gain. A negative value means the stock is already above intrinsic value.
-0.89x
Upside -86.5% vs downside 97.4% · Unfavourable
Margin of SafetyiA concept from value investing (Benjamin Graham). It measures how much cheaper the stock is compared to its intrinsic value. Positive margin = you're buying below fair value (safety cushion). Negative margin = you're paying more than the stock is fundamentally worth. Most value investors look for at least 15-25% margin of safety.
-643.1%
No margin
Forecast ConfidenceiShows how strongly the forecast is supported by available data, recent forecast behaviour and volatility. Higher confidence means the estimate has better historical support and lower uncertainty.
Moderate (63.8%)
Chance of upside: 0.0% · Avg forecast error: 10.43% · 589 data points
Fundamental FlooriThe lowest price the stock is expected to reach under normal market conditions, based on book value and financial strength (ROE, ROCE, debt ratios). A very low floor relative to CMP means the company has limited tangible asset backing at current prices. In extreme market crashes, prices can temporarily breach this level.
₹1.00
(97.4% below CMP)
52-Week Range
iShows the stock's lowest and highest closing prices over the past year (~252 trading days). The marker shows where today's price sits within that range. Near the low = potential value opportunity or ongoing weakness. Near the high = momentum or possible overextension.
₹33.20
₹118.00
CMP: ₹37.906% into range67.9% below 52W high
Monthly Return DistributioniBased on historical monthly returns (~21 trading days per month). Shows how many months the stock went up vs down, the best and worst single-month returns, and the win rate. A win rate above 55% with a positive average return indicates consistent performance. High best/worst spread = volatile returns.
Convergence TimelineiShows a possible timeline for the stock price to move closer to its intrinsic value. Milestones show estimated prices at 25%, 50%, 75% and 100% convergence. For overvalued stocks, convergence may indicate downside toward intrinsic value.
Target: ₹5.10 in ~5.0 years (2031)
Now ₹3825% ₹3050% ₹2275% ₹13Target ₹5
Gap: 86.5% downward · Assumed convergence period: 5.0 years
What this means: Fischer Medical Ventures Ltd appears overvalued by 86.5% relative to intrinsic value. The stock is currently in a bearish regime (price below EMA). A Hurst exponent of 0.39 suggests mean-reverting behavior — extreme moves tend to reverse. Volatility is high (348% annualized), implying wider price swings and higher risk.
Fischer Medical Ventures Ltd Year-Wise Share Price Target (2027–2036)
Year
Projected Price (₹)
Growth %
CAGR
2027
73.93
+95.1%
+95.1%
Month
Projected Price (₹)
Jan
36.55
Feb
35.40
Mar
51.14
Apr
69.79
May
57.49
Jun
49.31
Jul
47.24
Aug
59.11
Sep
58.40
Oct
49.66
Nov
69.30
Dec
73.93
2028
131.60
+247.2%
+86.3%
Month
Projected Price (₹)
Jan
69.17
Feb
86.65
Mar
91.42
Apr
83.59
May
102.25
Jun
126.54
Jul
134.09
Aug
142.08
Sep
164.05
Oct
138.86
Nov
157.09
Dec
131.60
2029
130.48
+244.3%
+51.0%
Month
Projected Price (₹)
Jan
183.36
Feb
169.37
Mar
176.90
Apr
171.29
May
151.53
Jun
153.54
Jul
197.60
Aug
204.32
Sep
175.23
Oct
164.46
Nov
139.20
Dec
130.48
2030
100.04
+164.0%
+27.5%
Month
Projected Price (₹)
Jan
148.97
Feb
148.21
Mar
133.13
Apr
131.79
May
128.86
Jun
127.55
Jul
125.98
Aug
89.63
Sep
88.70
Oct
114.67
Nov
111.53
Dec
100.04
2031
81.94
+116.2%
+16.7%
Month
Projected Price (₹)
Jan
103.52
Feb
77.98
Mar
90.43
Apr
78.79
May
73.35
Jun
77.06
Jul
89.42
Aug
107.80
Sep
114.31
Oct
97.48
Nov
88.26
Dec
81.94
2032
92.75
+144.7%
+16.1%
Month
Projected Price (₹)
Jan
82.51
Feb
90.00
Mar
78.26
Apr
63.96
May
85.13
Jun
97.14
Jul
99.05
Aug
95.23
Sep
109.74
Oct
112.93
Nov
117.61
Dec
92.75
2033
73.46
+93.8%
+9.9%
Month
Projected Price (₹)
Jan
101.24
Feb
78.58
Mar
94.94
Apr
93.36
May
84.01
Jun
101.45
Jul
87.22
Aug
93.47
Sep
92.22
Oct
89.70
Nov
76.26
Dec
73.46
2034
64.45
+70.1%
+6.9%
Month
Projected Price (₹)
Jan
61.83
Feb
61.18
Mar
61.62
Apr
66.18
May
51.13
Jun
52.09
Jul
62.67
Aug
81.40
Sep
101.31
Oct
89.65
Nov
88.11
Dec
64.45
2035
87.38
+130.6%
+9.7%
Month
Projected Price (₹)
Jan
67.76
Feb
87.49
Mar
97.57
Apr
114.64
May
124.75
Jun
137.81
Jul
131.89
Aug
116.46
Sep
106.42
Oct
87.61
Nov
87.20
Dec
87.38
2036
224.30
+491.8%
+19.5%
Month
Projected Price (₹)
Jan
95.31
Feb
104.88
Mar
106.17
Apr
98.98
May
132.48
Jun
171.13
Jul
186.08
Aug
154.11
Sep
158.43
Oct
164.61
Nov
224.89
Dec
224.30
Fischer Medical Ventures Ltd Stock Price Analysis
Avg Error (MAPE)iMean Absolute Percentage Error — the average difference between predicted and actual prices, expressed as a percentage. Lower is better. Below 2% = excellent, 2-5% = good, above 5% = the model struggles with this stock.
11.32%
Direction AccuracyiHow often the model correctly predicted whether the price would go up or down the next day. Above 55% = good (better than a coin flip). Above 60% = strong. This matters more than exact price accuracy for trading decisions.
57.1%
Avg Error (₹)iThe average rupee difference between predicted and actual closing prices. For a ₹100 stock, an error of ₹2 means predictions are typically off by about 2%. This gives you a sense of the prediction's precision in absolute terms.
₹20.06
PredictionsiTotal number of daily forecasts available for this stock. More observations improve the reliability of accuracy metrics and trend comparison.
Will Fischer Medical Ventures Ltd share price increase on the next market day?
Fischer Medical Ventures Ltd median forecast is ₹32.22 on 2026-05-18, which is 14.99% lower than today’s price of ₹37.90. The 10-90% forecast range is ₹32.22 to ₹32.22. Forecast confidence is 63.8%, with probability-up estimate of 0.0%. This estimate uses Getaka’s price-history, valuation-gap and volatility framework.
What is the intrinsic value of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd intrinsic value is ₹5.10, which is 86.54% below the current price of ₹37.90. This suggests the stock is currently overvalued.
What is the share price target of Fischer Medical Ventures Ltd in 2027?
Fischer Medical Ventures Ltd share price target for 2027 is projected to reach ₹73.93 by year-end (range: ₹35.40 to ₹73.93), representing a 95.07% increase from the current price of ₹37.90.
What is the share price target of Fischer Medical Ventures Ltd in 2028?
Fischer Medical Ventures Ltd share price target for 2028 is projected to reach ₹131.60 by year-end (range: ₹69.17 to ₹164.05), representing a 247.23% increase from the current price of ₹37.90.
What is the share price target of Fischer Medical Ventures Ltd in 2029?
Fischer Medical Ventures Ltd share price target for 2029 is projected to reach ₹130.48 by year-end (range: ₹130.48 to ₹204.32), representing a 244.27% increase from the current price of ₹37.90.
Should I buy Fischer Medical Ventures Ltd stock now?
Based on current analysis, Fischer Medical Ventures Ltd appears to be a consider reviewing your position candidate. Intrinsic value is ₹5.10 vs CMP ₹37.90. Use this as a research input and match it with your risk profile, investment horizon and portfolio plan.
What is the fundamental floor price for Fischer Medical Ventures Ltd?
The fundamental floor price for Fischer Medical Ventures Ltd is ₹1.00, calculated from book value and financial strength metrics (ROE, ROCE, debt-to-equity, interest coverage). This is the theoretical minimum price under normal market conditions.
Fischer Medical Ventures Ltd Share Price Prediction – How We Calculate the Targets
We calculate the share price targets for Fischer Medical Ventures Ltd using a combined approach of Geometric Fractional Brownian Motion (GFBM) and the Exponential Moving Average (EMA) for trend analysis. This hybrid model incorporates historical price data, memory effects through the Hurst exponent, and dynamic regime shifts based on the stock's trends. Below are the detailed steps of how these projections are calculated.
Step 1: Calculate the Log Returns
The log returns measure the relative change in stock prices over time. It is calculated as follows:
The Hurst exponent measures the "memory" or persistence of the stock price movement. It is calculated as follows:
\[ H = \frac{\log(R/S)}{\log(n)} \]
Step 6: Project Future Share Prices Using GFBM and EMA
The future price of the stock is projected using a combined model of Geometric Fractional Brownian Motion (GFBM) and Exponential Moving Average (EMA) for trend-based regime switching.
Step 7: Predicting Tomorrow's Stock Price for Fischer Medical Ventures Ltd
The next market-day price forecast uses price trend, volatility, valuation gap and regime adjustment. The displayed value is the median estimate, supported by a 10–90% uncertainty range.
Step 8: Projected Share Prices for the Next 10 Years
The projected share prices for the next 10 years are calculated using the combined GFBM and EMA model, taking into account historical growth, volatility, and market trends.
Conclusion
Our hybrid approach provides a realistic projection of share prices for Fischer Medical Ventures Ltd over the next 10 years by considering historical performance, volatility, market memory, and current trends.
The projected stock prices are informational estimates based on available data and assumptions. Past performance does not guarantee future results. Investors should consider risk profile, investment horizon, portfolio allocation and market risks before acting on any research output. Please read all relevant documents and terms carefully before investing.